NECTAR LIFESCIENCES
Back to Balance Sheet
|
NECTAR LIFESCIENCES Last 5 Year Contingent Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Contingent Liabilities | ₹198 Cr | ₹161 Cr | ₹76 Cr | ₹89 Cr | ₹72 Cr |
What is the latest Contingent Liabilities ratio of NECTAR LIFESCIENCES ?
Year | Contingent Liabilities |
---|---|
Mar2024 | ₹198 Cr |
Mar2023 | ₹161 Cr |
Mar2022 | ₹76 Cr |
Mar2021 | ₹89 Cr |
Mar2020 | ₹72 Cr |
How is Contingent Liabilities of NECTAR LIFESCIENCES Trending?
Years | Contingent Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹198 Cr | 22.75 | |
Mar2023 | ₹161 Cr | 113.41 | |
Mar2022 | ₹76 Cr | -15.46 | |
Mar2021 | ₹89 Cr | 24.86 | |
Mar2020 | ₹72 Cr | - |
Compare Contingent Liabilities of peers of NECTAR LIFESCIENCES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NECTAR LIFESCIENCES | ₹674.2 Cr | -16.3% | -25% | -11% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹409,003.0 Cr | -1.6% | -4.6% | 14.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹154,939.0 Cr | -1.6% | -1.3% | 61.6% | Stock Analytics | |
CIPLA | ₹117,835.0 Cr | 0.1% | 1.2% | 3.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹99,784.6 Cr | -2.1% | -8.7% | -2.3% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹90,722.1 Cr | -6.5% | -9.3% | 8.6% | Stock Analytics |
NECTAR LIFESCIENCES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NECTAR LIFESCIENCES | -16.3% |
-25% |
-11% |
SENSEX | -2.5% |
-1.4% |
6.1% |
You may also like the below Video Courses